Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales
FDA Law
DECEMBER 4, 2023
12, 2012). “[W]hen the circumstances surrounding the presentation of a prescription would give rise to suspicion in a ‘reasonable professional,’ there is a duty to question the prescription.” On October 10th, based on ability to pay, the U.S. 11, 2023 ( DOJ Press Release ). 21 U.S.C. § 829; 21 C.F.R. Holiday CVS, L.L.C. at 62,341.
Let's personalize your content